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Human cytomegalovirus (HCMV) can establish latent
infection in hematopoietic progenitor cells (HPCs)
or CD14 (+) monocytes. While circularized viral
genomes are observed during latency, how viral
genomes persist or which viral factors contribute to
genome maintenance and/or replication is unclear.
Previously, we identified a HCMV cis-acting viral
maintenance element (TR element) and showed
that HCMV IE1 exon 4 mRNA is expressed in latently
infected HPCs. We now show that a smaller IE1 pro-
tein species (IE1x4) is expressed in latently infected
HPCs. IE1x4 protein expression is required for viral
genome persistence and maintenance and replica-
tion of a TR element containing plasmid (pTR). Both
IE1x4 and the cellular transcription factor Sp1
interact with the TR, and inhibition of Sp1 binding
abrogates pTR amplification. Further, IE1x4 interacts
with Topoisomerase IIb (TOPOIIb), whose activity is
required for pTR amplification. These results identify
a HCMV latency-specific factor that promotes viral
chromosome maintenance and replication.
INTRODUCTION
Human cytomegalovirus (HCMV) can cause significant disease
and mortality in immune-compromised individuals. It is well
established and accepted that HCMV latent infection occurs
primarily in CD34 (+) hematopoietic progenitor cells (HPCs) or
CD14 (+) monocytes (Goodrum et al., 2002; Maciejewski et al.,
1992; Mendelson et al., 1996; Reeves et al., 2005; Sinclair and
Sissons, 1996; Sissons et al., 2002; So¨derberg-Naucle´r et al.,
1997; Taylor-Wiedeman et al., 1991; Zhuravskaya et al., 1997).
Although latency has been studied in a variety of natural and
experimental systems, the mechanisms involved in HCMV
genome maintenance are poorly understood. It was previously
reported that the viral genome is apparently circularized during
latency in CD14 (+) monocytes (Bolovan-Fritts et al., 1999). How-
ever, beyond this observation little is known regarding how viral
genomes persist in latently infected cells and which viral-
encoded factors contribute to genome maintenance and/or
replication.
Recent analysis of nucleosome occupancy in the HCMV latent
chromosome revealed that the terminal repeat (TR) region wasCdepleted of nucleosomes. Subsequent subcloning of the TR
region into a plasmid vector showed that this region of the
HCMVgenomemediatedviral chromosomepersistence in latently
infected CD14 (+) cells (Rossetto et al., 2013). These results
strongly suggested that the TR element of the HCMV genome
was sufficient for episome maintenance in latently infected cells.
Several previous studies identified specific viral transcripts
associated with latent infection in various cell types (Bego
et al., 2005, 2011; Goodrum et al., 2007; Jenkins et al., 2008;
Khaiboullina et al., 2004; Kondo and Mocarski, 1995; Kondo
et al., 1996; Kotenko et al., 2000). Recent published data from
our laboratory using RNA-seq revealed the viral transcriptome
from both experimentally and naturally HCMV latently infected
CD14 (+) and CD34 (+) HPCs (Rossetto et al., 2013). HCMV
transcriptome analysis confirmed the expression of previously
identified latency-associated transcripts and identified the
expression of several other mRNAs. These studies also showed
that gene expression during experimental latency closely
mirrored those transcripts expressed in natural latency. One sur-
prising result from these studies was the observation that HCMV
IE1 mRNA was detected in latently infected HPCs, but not in
CD14 (+) monocytes, in the absence of IE2 mRNA in both natural
and experimental latency systems. Since IE1 was shown to
interact with mitotic chromosomes (Lafemina et al., 1989), the
presence of IE1 during latency suggests that maintenance of
the latent viral genome may occur through a mechanism
involving tethering of the viral genome to the host cell chromatin
(Mu¨cke et al., 2014). This is not unlike the mechanism used by
Kaposi’s sarcoma-associated virus (KSHV) and Epstein-Barr
virus (EBV) to maintain and propagate their latent virus genomes.
We now show that the plasmid containing the HCMV TR
element persists in latently infected HPCs and demonstrate
that the presence of IE1x4 is sufficient to maintain and replicate
the TR plasmid, pTR. Also, western blot analysis of latently in-
fected HPCs revealed that a smaller than wild-type IE1 protein
species is expressed during latency. These studies strongly
suggest that HCMV genome maintenance/replication requires
the cis-acting TR element and the expression of the latency-spe-
cific IE1x4 protein.
RESULTS
IE1x4 Is Expressed in the Absence of Exons 2 and 3 in
HCMV Latently Infected CD34 (+) HPCs
Initial strand-specific RNA-seq data showed that IE1 (exon 4) but
not IE2 mRNA was present in HCMV latently infected HPCs
(Rossetto et al., 2013). This interesting observation prompted
us to further investigate the origin of the IE1 transcript in latentlyell Host & Microbe 16, 43–54, July 9, 2014 ª2014 Elsevier Inc. 43
Figure 1. Expression of IE1x4 in Latently
Infected CD34 (+) Cells
(A) Schematic of major immediate early region
showing exons 1–5. Also shown are PCR primers
used for RT-PCR from HCMV latently infected
CD34 (+) cells, infected HFs, or an IE1-expressing
HF cell line (gift from E. Mocarski). GAPDH control
PCR amplifications are also shown.
(B) RT-PCR from latently infected or HF-infected
cells and schematic of 50 RACE showing putative
IE1x4 protein initiation sites. The number of cDNA
subclones isolated for each RNA start is shown in
parentheses.
(C) Western blots of protein lysates prepared from
either HF-infected cells, the HF IE1 cell line, or
latently infected CD34 (+) cells. Arrows identify IE1
and IE2 protein species. IE1L refers to the IE1
species observed in latently infected CD34 (+)
cells. Blots were initially reacted with anti-iE1
antibody and then reacted with anti-iE2-specific
antibody. Mock infected cells reactedwith anti-iE1
are also shown. Actin shows the relative amounts
of protein lysate loaded for visualization of IE1
species and comparison of their respective mo-
lecular weights. Mock infected cells reacted with
anti-iE1 are also shown.
(D) Latently infected CD34 (+) HPCs or reactivated
cells were subjected to ChIP using an antibody
specific for RNAPII. Immunoprecipitated DNAwas
quantitated by qPCR and compared to input
samples. Graph shows RNAPII occupancy during
latency and reactivation at specific genomic re-
gions of the MIE gene loci. Error bars are the
standard deviation from the mean for three sepa-
rate experiments.
(E) Full-length IE1 is expressed upon reactivation
of HCMV latently infected CD34 (+) HPCs. Blot
was reacted with an IE1-specific antibody. Lane 1:
immunoprecipitated IE1 from reactivated CD34 (+)
cells; IE1 and antibody heavy-chain IgG are indi-
cated by black arrows. Lane 2: mock infected
CD34 (+) cells. Lane 3: 4 days postinfection HF
cells. Lane 4: mock infected HF cells.
(F) Production of infectious virus from reactivated,
latently infected CD34 (+) HPCs. After reactivation,
HPCs were cocultured with human fibroblasts for
10 days. Shown is a photomicrograph image of
HCMV-infected HF cells with reactivated FixBac
virus. See also Figure S1.
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were monitored for the expression of IE2 mRNA (Figure S1A).
Reverse-transcriptase PCR (RT-PCR) from latently infected cells44 Cell Host & Microbe 16, 43–54, July 9, 2014 ª2014 Elsevier Inc.was performed using PCR primers com-
plementary to IE1- or IE2-specific tran-
scripts (Figure 1A). PCR products were
detected only when using IE1 exon 4-
specific primers (Figure 1B, lane 20),
whereas primers for exons 2–3 showed
no PCR product (Figure 1B, lane 4).
Also, no product was detected when
primers spanning exons 3–4 were used
(Figure 1B, lane 12). Hence, PCR datasuggested that only exon 4mRNAwas expressed and not exons
2 and 3 in HCMV latently infected HPCs. Positive controls, lyti-
cally infected human fibroblast (HF) RNA, show the presence
Figure 2. Amplification of pTR in Experimentally and Naturally
Infected CD34 (+) Cells
Experimentally infected CD34 (+) HPCs transfected with pTR or pGEM. Data
were calculated as fold change verses input DNA. Error bars are the standard
deviation from the mean for three separate transfections. Plasmid copy
number is shown in parenthesis. See also Figure S2A.
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IE1x4 Mediates Latent Viral Genome Maintenanceof all IE1/IE2 spliced products (Figure 1B). Negative controls (no
reverse transcriptase) showed no specific PCR product. We also
performed 50 RACE on mRNA isolated from latently infected
cells. RACE results suggest two possible mRNA initiation sites
for IE1x4 in latently infected cells (Figure 1B).
We next evaluated protein expression of IE1 in HCMV latently
infected HPCs. Western blots show that, during HCMV latent
infection of HPCs, a smaller MW species of IE1 protein
(60 kDa) was expressed when compared to IE1 protein de-
tected during lytic infection in HF cells or from an HF cell line
that expresses IE1 (Figure 1C, compare lane 3 to lanes 1 and
2). As expected, no IE2 protein was detected in latently infected
HPCs, whereas IE2 was readily detected during lytic infection of
HF cells (Figure 1C). Mock infected HPCs showed no specific
protein band when reacted with anti-iE1 antibody (Figure 1C,
lane 7). Also, IE2-60 and IE2-40 protein species were detected
in infected HFs using anti-iE2-specific antibody, since these
proteins originate from transcripts produced within exon 5 (Fig-
ure 1C, lane 4). We also confirmed the smaller IE1 species using
a different IE1-specific antibody (Figure S1B). We performed an
immunoprecipitation (IP) assay using IE1 antibody to show that,
during HCMV latency in HPCs, no full-length IE1 protein was de-
tected (Figure S1C). These experiments indicated that a smaller
species of IE1 is specifically expressed during an HCMV latent
infection of HPCs.
The major immediate early promoter (MIEP) regulates expres-
sion of the HCMVMIE proteins IE2 and IE1 (Figure 1D). However,
the observation that a smaller species of IE1, comprising only
exon 4, suggests that a distinct promoter upstream of exon 4
regulates expression of this latency-specific IE1 variant. RNA
polymerase II (RNAPII) quantitative ChIP assays were performed
using latently infected HPCs or reactivated HPCs. Occupancy of
RNAPII was highest at the MIEP region (Figure 1D). However, noCRNAPII was detected within exons 1 or 2. RNAPII occupancy
was detected upstream of exon 4 within exon 3, as well as within
exon 4 (Figure 1D), suggesting active transcription from exon 4.
In HCMV lytically reactivated samples, RNAPII again showed a
high degree of occupancy at the MIEP region however it
was distributed throughout the MIE locus (Figure 1D). Taken
together, these results strongly suggest that transcription initia-
tion for IE1x4 occurs within theMIE locus and confirms the quan-
titative PCR (qPCR) and western blot results showing that IE1x4
is transcribed during latency.
We also investigated IE1 expression from reactivated cells.
Interestingly, full-length IE1 protein was produced upon reacti-
vation (Figure 1E). Reactivated cells were incubated with HFs
to confirm that infectious virus was produced (Figure 1F).
Expression of IE1x4 is apparently restricted to latent infection,
as evidenced by the production of full-length IE1 upon lytic reac-
tivation of HPCs.
To identify the origin of the smaller IE1 protein species present
during a latent infection of HPCs, we immunoprecipitated IE1
protein and sequenced the precipitated protein using LC/MS.
Immunoprecipitated IE1x4 was sequenced (>80% coverage)
and identified a putative start for the protein as the second
ATG within exon 4 (Table S1).
HCMV TR Is Replicated and Maintained in Latently
Infected CD34 (+) HPCs
FixBac latently infected HPCs (experimental) were transfected
with pTR or pGEM. High-efficiency transfection of HPCs was
achieved using a Nucleofector device (Figure S2A). The plasmid
containing the HCMV terminal repeats (pTR) wasmaintained and
amplified (resistant to DpnI cleavage) (Figure 2A, pTR). However,
control pGEMDNAwas not (Figure 2A, pGEM). The results of this
experiment show that the TR region could persist and replicate in
infected HPCs and strongly suggest that the TR region of the
circular HCMV genome is the episomal maintenance element
for the viral chromosome.
We also identified factors that interact with HCMV TR by em-
ploying an in vitro affinity column protocol using nuclear extracts
from latently infected HPCs. Table S2 shows the results of the
proteomics study where viral proteins listed had confidence
scores greater than 95%. Proteomics identified IE1 as a possible
viral encoded protein that interacts with the TR (Table S2).
IE1x4 Interacts with the TR during Latent Infection of
CD34 (+) HPCs
To confirm the proteomics in vitro findings, an IE1 ChIP was
performed in latently infected HPCs. ChIP DNA was PCR ampli-
fied using primers for the TR element or a negative control region
(UL25) of the viral genome. IE1x4 did indeed interact with the TR
element, whereas negative controls showed no detectable inter-
actions (Figure 3A). These experiments demonstrate that IE1
interacts with HCMV TR and could potentially tether the latent
viral genome to the cellular DNA, consistent with what was pre-
viously reported (Mu¨cke et al., 2014).
IE1 protein contains a chromatin tethering domain (CTD) and
an acidic domain (AD) (Huh et al., 2008; Ahn et al., 1998; Krauss
et al., 2009; Shin et al., 2012). To determine if the AD or CTD
mediated the interaction of IE1x4 with the TR, 293FT cells
were cotransfected with pTR along with plasmids that expressell Host & Microbe 16, 43–54, July 9, 2014 ª2014 Elsevier Inc. 45
Figure 3. IE1 Interacts with the TR Element
during Latent Infection of CD34 (+) HPCs
and Identification of IE1 Binding Consensus
Sequences by ChIP-Seq
(A) ChIP assay in latently infected HPCs with anti-
iE1-, GAPDH-, or isotype control-specific anti-
bodies. Lanes: input DNA, isotype control
antibody, immunoprecipitation using anti-GAPDH
antibody or IE1-specific antibody.
(B) 293FT cells were cotransfected with pTR and
either pIE1-FL-GFP, pIE1-AD-GFP, pIE1-CTD-
GFP, or empty pEGFP vector. ChIP assays were
performed using anti-EGFP-specific antibody and
PCR primers specific for the TR region.
(C) Elucidation of viral (using latently infected
CD34 (+) HPCs) and cellular (using noninfected
CD34 (+) HPCs transfected with IE1-CTD-GFP)
DNA binding motifs using ChIP-seq. Shown is the
RSAT analysis identifying putative DNA motifs
from either viral or cellular DNA. A consensus
sequence containing Sp1 transcription factor
binding sites was identified for viral DNA. A
consensus sequence containing a 5 bp tandem
repeat (boxed) was identified in the cellular data.
(D) Schematic of the HCMV TR region showing the
presence of putative Sp1 sites and the relative
positions of DNA elements. See also Figure S2B.
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and S2C). Plasmids expressing EGFP alone or full-length IE1-
EGFP were also used as negative and positive controls, respec-
tively (CTD and full-length are gifts from E. Mocarski). The ChIP
assay shows that AD-EGFP interacted with the TR region,
whereas no PCR product was detected from CTD-EGFP or
EGFP transfections (Figure 3B). These experiments confirmed
that IE1 interacts with the TR region in the absence of other viral
proteins, and the interaction is most likely mediated through the
acidic domain (AD) of the protein.
Identification of IE1 DNA Binding Motifs in CD34 (+)
HPCs
Previous studies showed that IE1 interacts with mitotic chromo-
somes through the CTD of IE1 (Lafemina et al., 1989). Although
this domain does not contribute to lytic DNA replication in human
fibroblasts (Reinhardt et al., 2005; Shin et al., 2012), we were
interested in determining the viral and host cell chromatin DNA
interaction motifs for IE1 in HPCs. For viral chromatin/IE1 inter-
actions, latently infected HPCs were used for a ChIP-seq exper-
iment with IE1 antibody followed by next-generation sequencing
(NGS). For cellular-specific chromatin/IE1 interactions, we trans-
fected noninfected HPCswith the IE1 CTD-EGFP plasmid. EGFP
antibody was used for IP followed by NGS. DNA binding
domains were identified by peak calling with CLC Genomics
Workbench software and uploading the peak sequences to a
motif identifier specific for large NGS data sets (Regulatory
Sequences Analysis Tools, RSAT). ChIP-seq data are available
at NCBI SRA under accession number SRP040115.
RSAT analysis of ChIP-seq data from latently infected HPCs
showed that IE1 interacted with putative Sp1 motifs (Figure 3C,
Viral DNA). Multiple Sp1 consensus sequences are present
within the HCMV TR element (Figure 3D). This is consistent46 Cell Host & Microbe 16, 43–54, July 9, 2014 ª2014 Elsevier Inc.with the IE1 binding shown to occur within the TR element in
ChIP experiments shown in Figure 3A. For cellular DNA binding,
the CTD of IE1 interacted with a 5 bp tandem repeat DNA motif
that is specific to centromeres of chromosomes 1, 8, and 10 (Fig-
ure 3C, Cellular DNA) (Alkan et al., 2011; Muro et al., 1992; Zhu
et al., 1995, 1996). This report of an IE1 cellular chromatin-
binding motif suggests that IE1 interacts with centromeres of
cellular chromatin in HPCs. These data strongly suggest that
IE1 interacts with both the latent viral genome and cellular chro-
matin during latency and implicates IE1 as a latent viral genomic
DNA maintenance factor.
Expression of IE1x4 Is Required for Long-Term
Maintenance of Viral DNA in CD34 (+) HPCs
We generated an IE1 exon 4 deletion FixBac recombinant
virus, FixBacDEX4 (Figure 4A), and revertant. FixBacDEX4 was
confirmed by Southern blot (Figure 4B), and the final BAC clone
was sequenced. Consistent with what was previously described,
the FixBacDEX4 mutant was reconstituted using an IE1-
expressing cell line (a gift from E. Mocarski; IE1 expression
shown in Figure 1C) and achieved viral titers equal to wtFixBac
virus in infected HFs (data not shown).
FixBacDEX4 or wtFixBac was used to infect HPCs, and viral
DNA accumulation was monitored by PCR over a 35 day period.
At 35 days postinfection, FixBacDEX4 viral DNA was undetect-
able, whereas wtFixBac virus was still detectable by PCR (Fig-
ure 4C). Revertant virus DNA was also detectable (data not
shown). PCR for the c-fos cellular gene promoter served as a
control (Figure 4C). qPCR for FixBacDEX4 gene expression
showed a similar gene profile when compared to wtFixBac infec-
tion of HPCs (Figure S3, compare LUNA day 19), suggesting that
the lack of genome persistence was not due to the aberrant
expression of latency-associated factors. qPCR evaluation of
Figure 4. IE1 Is Required for Long-Term Maintenance of HCMV Genomic DNA
(A) Schematic of FixBacDEX4 showing the IE locus and probes used for Southern blot.
(B) Agarose gel and Southern blot of FixBac cleaved DNA showing insertion of GalK cassette (left panels) and subsequent removal to yield a deletion in exon 4
(right panels).
(C) FixBacDEX4 or WT FixBac virus was used to infect CD34 (+) HPCs, and viral genomic DNA was monitored by PCR for viral and cellular loci at various days
postinfection.
(D) qPCR evaluation of viral genomic DNA accumulation for wtFixBac, FixBacDEX4, and revertant virus (FixBacRev). Shown is the viral genomic DNA as a percent
of total DNA using the cellular RNA 7SK gene locus as a reference for total DNA. Three separate experiments were performed, and error bars are the standard
deviation of the mean from three experiments. See also Figure S3.
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PCR results by also showing that FixBacDEX4 failed to maintain
genomic DNA (Figure 4D). These results strongly suggest that
IE1x4 expression is required for long-term HCMV genomic
DNA persistence in HPCs.
IE1x4 Mediates pTR Maintenance and Replication
We investigated if IE1x4 could mediate replication and mainte-
nance of pTR by making a recombinant lentivirus that expressed
IE1x4 (Figure 5A) to generate a 293L cell line that constitutively
expressed IE1x4 (Figure 5B). This cell line, 293-IE1x4, was trans-
fected with pTR or pGEM, and cells were passed up to 20 times
in culture. The accumulation of DpnI-resistant pTR DNA was
calculated compared to pGEM control transfected cells. At cell
passage five, there were approximately 41 copies of pTR per
cell and a 13-fold increase in replicated DNA versus control
samples (Figure 5C). At cell passages 10 and 20, pTR copy
number stabilized at approximately two copies per cells (Fig-
ure 5C). Results also showed that the IE1x4 AD is required for
amplification of pTR in the transient assay (Figure S4). These
data strongly suggest that expression of IE1x4mediates mainte-
nance and replication of pTR.
IE1 Interacts with TOPOIIb, and Inhibition of TOPOIIb
Results in a Decrease in pTR Amplification
It was recently shown that HCMV IE1 interacts with cellular chro-
matin in a manner consistent with KSHV LANA (Mu¨cke et al.,C2014), and KSHV LANA interacts with TOPOIIb (Purushothaman
et al., 2012). Given the fact that IE1x4 mediates viral DNA repli-
cation and maintenance during latency, we investigated if
IE1x4 interacts with TOPOIIb. IP experiments show that IE1x4
interacts with TOPOIIb (Figure S5A). Treatment of samples with
DNase had no effect on the ability to coimmunoprecipitate
TOPOIIb and IE1x4, strongly suggesting that the binding of the
two proteins was the result of a protein-protein interaction (Fig-
ures S5E and S5F). Since IE1x4 was shown to interact with the
HCMV TR region in latently infected HPCs, we evaluated
TOPOIIb binding to the TR during latency. ChIP experiments
confirm that TOPOIIb interacts with the TR region during latency
(Figure S5B). Hence, data suggest that IE1x4 recruits at least one
factor involved in DNA replication to the HCMV TR element dur-
ing a latent infection.
Next, 293-IE1x4 cells were transfected with pTR and treated
with Ellipticine, a drug that inhibits TOPOIIb. In the presence of
Ellipticine, the expression of IE1x4 was unaffected (Figure 6A);
however, the accumulation of replicated pTR was dramatically
reduced compared to DMSO control treated cells (Figure 6B).
As a control for Ellipticine activity, we also evaluated cell cycle
by flow cytometry to show that Ellipticine arrested cells in the
S and G2 phases of the cell cycle (Riccardi and Nicoletti, 2006)
(Figures 6C and S5G). These experiments suggest that IE1x4
recruits TOPOIIb to the TR element in latently infected cells
and that HCMV latent DNA replication requires the activity of
TOPOIIb.ell Host & Microbe 16, 43–54, July 9, 2014 ª2014 Elsevier Inc. 47
Figure 5. IE1 Exon 4 Mediates Amplification
of HCMV Terminal Repeat Plasmid
(A) Generation of recombinant lentivirus express-
ing IE1x4. Exon 4 (blue) was subcloned from
amino acid 95 to amino acid 491 into the lentiviral
expression vector pLVX EF1a.
(B) Western blot showing expression of IE1x4 in
the stably transduced 293L-IE1x4 cells. Lane 1:
mock infected HF cells. Lane 2: 4 day post-
infection HF cells. Lane 3: mock infected 293L
cells. Lane 4: IE1x4 293L stable cell line.
(C) IE1x4 mediates amplification of pTR. 293L cell
line that expresses IE1x4 was transfected with
pTR. Hirt extracts were performed, and fold
increase in DpnI-resistant DNA was determined,
as was plasmid copy number. Error bars are the
standard deviation for three biological replicates.
pTR copy number is shown in parentheses. See
also Figure S4.
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Amplification and Binding of IE1x4 to the TR Element
CoIP and ChIP experiments confirm interaction of Sp1 with
IE1x4 and TR, respectively (Figures S5C and S5D). We next
treated 293-IE1x4-expressing cells transfected with pTR with
Mithramycin A (Mith A), a drug that binds to GC-rich DNA se-
quences and displaces Sp1 transcription factor binding (Blume
et al., 1991; Snyder et al., 1991). Since it is known that the
c-Myc gene is highly regulated by Sp1, we evaluated the accu-
mulation of c-Myc mRNA and protein from cells treated with
Mith A as a measure of the drug’s efficacy in our cell line. Mith
A-treated cells showed a decrease in c-Myc mRNA and protein
expression (Figures 7A and 7B). ChIP assays at 3 days posttreat-
ment with Mith A were performed using Sp1 or IE1 antibodies
and PCR primers for the HCMV TR or, as a negative control,
the myoglobin exon 2 genomic region. In the presence of Mith
A, the interaction of IE1x4 or Sp1 with the TR element was no
longer detectable (Figure 7C, IE1x4 Mith A). qPCR results
confirmed a marked decrease in occupancy of IE1x4 at the TR
element in the absence of Sp1 binding at the TR (Figure S6A).
We next evaluated the ability of pTR to amplify in the absence
of Sp1 and IE1x4 binding with the TR element. DNA from Mith
A- or DMSO-treated IE1x4-expressing cells transfected with
pTR was Hirt extracted at 1 and 5 days posttreatment and eval-
uated for plasmid amplification. No amplification of pTR was
detected at 5 days posttreatment in the presence of Mith A (Fig-
ure 7D). Lastly, we evaluated the ability of IE1x4 to interact with
the TR element in HPCs infected with FixBac virus and treated
with Mith A. Mith A-treated cells were evaluated for expression
of c-Myc to ensure that Sp1 binding to the c-Myc promoter
was inhibited (Figure S6B). DMSO and treated infected cells
were harvested, and ChIP assays were performed using Sp1
or IE1 antibodies. The amount of IE1x4 that interacted with the
TR element in infected cells decreased in the absence of Sp1
interaction with the TR element (Figure 7E). Mith A had a mini-
mum effect on cell viability at 50 nM at 5 days posttreatment
(Figure S6C).
Since Mith A treatment likely results in off-target effects, we
performed Sp1 knockdown experiments in the context of the48 Cell Host & Microbe 16, 43–54, July 9, 2014 ª2014 Elsevier Inc.transient assay to further support the involvement of Sp1 in TR
replication. 293 cells were transduced with either a lentivirus
that expressed shRNA specific for Sp1 mRNA or a control
scramble shRNA. Efficient knockdown of Sp1 expression was
confirmed by western blot (Figure 7F). shRNA-treated cells
were cotransfected with a pEGFP-IE1x4 plasmid and pTR.
ChIP assays were performed using antibodies for IE1, Sp1, or
GAPDH and primers specific for the TR element or the cellular
myoglobin exon 2 genomic locus. In cells where Sp1 expression
was knocked down, the amount of IE1x4 occupying the TR
element was reduced (Figure 7G). Lastly, wemeasured the accu-
mulation of replicated pTR under conditions where Sp1 expres-
sion was knocked down in the transient assay. Amplification of
pTR was reduced in cells expressing shRNA specific for Sp1
mRNA (Figure 7H). Taken together, Sp1 shRNA knockdown or
drug-induced inhibition of Sp1 binding to its consensus
sequence reduces the amount of IE1x4 binding to the TR
element and results in a reduction in amplification of pTR. These
results suggest that Sp1mediates a required interaction of IE1x4
for the amplification and maintenance of the HCMV TR.
We also evaluated the ability of pTR to amplify when a cluster
of Sp1 sites was removed from the TR element (Figure S7A). The
removal of a cluster of Sp1 sites from pTR abrogated the ability
of the plasmid to replicate in the presence of IE1x4 (Figure S7B)
and reduced the occupancy of Sp1 at the TR (Figure S7C), sug-
gesting that the region of the TR containing a cluster of Sp1 sites
is required for efficient latent DNA replication.
Comparison of KSHV and HCMV latency cis- and trans-acting
factors shows some similarities between IE1x4 and LANA and
KSHV TR and HCMV TR (Mu¨cke et al., 2014) (Figures S7D and
S7E, respectively).
DISCUSSION
One striking difference betweenHCMV latency in CD34 (+) HPCs
and CD14 (+) monocytes was that the transcript encoding IE1x4
was present in HPCs (Rossetto et al., 2013). One explanation for
this difference is that two distinct mechanismsmay have evolved
to maintain the viral chromosome in CD34 (+) cells verses
Figure 6. Inhibition of TopoisomeraseIIb
with Ellipticine Abrogates pTR Replication
in the Transient Replication Assay
(A) Western blot of IE1x4 expression in the 293L-
IE1x4 cell line treated with 10 mM Ellipticine.
(B) Inhibition of TOPOIIb activity with Ellipticine
diminishes pTR amplification. 293-IE1x4 cells
were transfected with pTR and treated with
Elllipticine or DMSO. qPCR was used to measure
the enrichment of replicated plasmid DNA relative
to input DNA. Three separate experiments were
performed, and error bars are the standard devi-
ation of the mean from three experiments.
(C) Flow cytometry of propidium iodide-stained
293L-IE1x4 cells treated with DMSO or Ellipticine
for 3 days. Curve fitting to determine percentage
of cells in each cycle was performed using the
Watson method. The fitted histograms are shown
in Figure S5.
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fact that monocytes are short-lived, nondividing cells in vivo,
whereas CD34 (+) HPCs are a long-lived, self-renewing cell pop-
ulation (Kataoka et al., 2011; Kikushige et al., 2011; Piacibello
et al., 1998; Reya, 2003; Reya et al., 2003; Seita and Weissman,
2010; Wilson et al., 2004; Zon, 2008). Hence, viral genome
persistence may depend on efficient tethering and maintenance
in a self-renewing cell type such as CD34 (+) HPCs.
Although the presence of IE1 mRNA in infected HPCs was
reported previously (Maciejewski and St Jeor, 1999), we
observed expression of a protein originating entirely from exon
4 in the same reading frame context as full-length IE1. RNAPII
occupancy data show that transcription from the MIEP is stalled
and that an internal promoter most likely regulates the expres-
sion of IE1x4 in HPCs. The sequence upstream of IE1x4 contains
multiple transcription factor binding sites including AP-1,
GATA-1, STAT, and c-ETS. The expression of only exon 4 in
the absence of exons 2 and 3 may explain why many previous
studies failed to detect the IE1 mRNA during latent infection by
PCR, since primers specific for exons 2 and 3 are typically
used to show the absence of IE1/IE2 in latently infected HPCs.
These data are also in agreement with previous observations
showing that epigenetic modifications as well as control of
transcriptional elongation are significant factors regulating
herpesvirus latent virus gene expression (Abraham and Kulesza,
2013; Palermo et al., 2011; Toth et al., 2012).
Similar to KSHV LANA, which also interacts with DNA through
histones, ChIP-seq data suggest that IE1x4 associates with
mitotic chromosomes with a preferential localization to areas
near centromeres (Va´zquez et al., 2013). We postulate that
HCMV IE1x4 functions in the same capacity as EBNA1 and
LANA in that they tether viral genomic DNA to cellular chromatin
and mediate amplification of the viral genome (Barbera et al.,Cell Host & Microbe 16,2006; Ceccarelli and Frappier, 2000;
Cotter and Robertson, 1999; Fujita
et al., 2001; Ito et al., 2002; Marechal
et al., 1999; Nayyar et al., 2009;
Piolot et al., 2001; Wang and Frappier,
2009). This premise was reinforcedrecently by the published report showing that IE1 and LANA
share some of the same properties with respect to interaction
with DNA through histones (Mu¨cke et al., 2014). Also, the TR
region of HCMV, which mediates episome persistence, is
consistent with the location of the viral DNA maintenance
element in KSHV (Ballestas et al., 1999; Ballestas and Kaye,
2001; Collins and Medveczky, 2002; Cotter et al., 2001; Garber
et al., 2001; Lim et al., 2002). The KSHV maintenance element
or latent origin contains several LANA binding sites, of which at
least one is required for efficient plasmid replication (Garber
et al., 2001). EBV OriP is also composed of complex repeat
elements and contains EBNA-1 binding sites (Yates et al.,
2000). In both EBV and KSHV, latent origins are G+C rich and
contain multiple repeat sequences; this is consistent with the
sequence of the TR region of HCMV. HCMV TR interacts with
components of the cellular replication machinery, which is again
consistent with EBV OriP and KSHV TR regions (Aiyar et al.,
1998; Chaudhuri et al., 2001; Dhar et al., 2001; Rossetto et al.,
2013; Schepers et al., 2001; Stedman et al., 2004).
The work presented here supports a model of HCMV latency
where a viral-encoded protein, IE1x4, interacts with the TR
region and acts in trans to replicate and maintain the viral
genome in HPCs. We show that IE1x4 interacts with Sp1 in the
context of the transient TR replication assay. Using this assay
we show that inhibition of binding of Sp1 to the TR also
decreased the amount of IE1x4 interacting with the TR in both
transiently transfected cells. The lack of binding of Sp1 and
IE1x4 to the TR element resulted in a decrease in amplification
of the TR-containing plasmid, adding more weight to the evi-
dence that IE1x4 is the viral-encoded factor regulating viral
genome maintenance and replication. The interaction of IE1
with Sp1 was previously described in HCMV lytically infected
cells (Yurochko et al., 1997). Lastly, we demonstrate that IE1x443–54, July 9, 2014 ª2014 Elsevier Inc. 49
Figure 7. The Interaction of Sp1 with the HCMV TR Is Required for Amplification and Binding of IE1x4 to the TR Element
(A) Treatment of cells with MithA decreases the expression of c-Myc RNA. qPCR showing relative expression levels of mRNA in DMSO- or Mith A-treated 293-
IE1x4 cells was calculated using cyclophilin mRNA as an internal control.
(B) Mith A decreases the expression of c-Myc protein. We performed western blots of cells treated with increasing concentrations of Mith A. Blots were reacted
with anti-c-Myc, IE1, or GAPDH.
(C) ChIP assays showing inhibition of Sp1 binding to the HCMV TR also blocks IE1x4 interaction with the TR element. 293-IE1x4-expressing cells were trans-
fected with pTR and treated with Mith A or DMSO.
(D) pTR amplification in 293-IE1x4 cells transfected with pTR or pGEM and treated with Mith A or DMSO. At 1 and 5 days posttreatment, DNA was analyzed for
DpnI resistance. qPCR was used to measure the enrichment of replicated plasmid DNA relative to input DNA.
(E) ChIP assay of latently infected HPCs treated with Mith A or DMSO. Occupancy relative to GAPDH was measured for each protein at the TR or myoglobin
genomic region.
(F) Western blot of Sp1 knockdown in 293L cells relative to a scramble control cell line and expression of transfected pEGFP-IE1x4.
(G) ChIP assay showing knockdown of Sp1 reduces IE1x4 binding to TR. Occupancy is calculated relative to GAPDH.
(legend continued on next page)
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IE1x4 Mediates Latent Viral Genome Maintenanceinteracts with at least one cellular replication protein, TOPOIIb,
also consistent with KSHV LANA. Hence, the DNA sequence
properties and location of the HCMV TR, coupled with the obser-
vation that IE1 mediates persistence of the pTR plasmid,
strongly suggest that the TR element is the functional equivalent
of KSHV and EBV latent origins and that IE1 is the functional
equivalent of LANA and EBNA1.
Data show that IE1x4 is the only viral-encoded protein
required to both amplify the viral genome and mediate efficient
transfer to daughter cells, although other factors expressed
during HCMV latency in HPCs may contribute to maintenance/
replication of the viral genome. pTR copy number stabilized at
approximately two copies per cell after 20 cell passages, consis-
tent with what was observed for EBV OriP (Leight and Sugden,
2001). During lytic infection HCMV IE1 interacts with STAT1/
STAT2 and subsequently counteracts type I IFN-mediated anti-
viral host response during lytic infection (Huh et al., 2008; Krauss
et al., 2009; Paulus et al., 2006). Also, IE1 localizes with and
disrupts ND10 compartments through an interaction with PML
(Ahn and Hayward, 1997, 2000; Korioth et al., 1996; Wilkinson
et al., 1998). These properties of IE1 are thought to facilitate an
evasion of host cell immune response leading to enhanced virus
replication and growth under lytic conditions (Korioth et al., 1996;
Tavalai et al., 2006).
In summary, we provide evidence for a mechanism of HCMV
genomemaintenance in latently infected HPCs involving expres-
sion of IE1x4. The factor described in this study is specific to
HCMV latent infection in CD34 (+) HPCs and mediates viral
genome maintenance and replication.
EXPERIMENTAL PROCEDURES
Western Blots for the Detection of HCMV IE1 in CD34 (+) HPCs
IE1 western blots were performed with approximately 13 106 latently infected
CD34 (+) HPCs lysed in Laemmli sample buffer, and protein lysates were sepa-
rated through an 8%–16% SDS-PAGE gel. Protein was transferred to PVDF
membranes and reacted with either a commercially available IE1 antibody
(exon 4-specific, Abcam #ab30924) at 1:1,000 or with an IE1 antibody (p63-
27) generously gifted from William Britt at 1:20,000 (Andreoni et al., 1989; Britt
and Vugler, 1987). A mouse IgG LI-COR fluorescent secondary antibody was
used at 1:5,000, and imaging was performed using a LI-COR scanner. Blots
were reacted with an anti-actin-specific antibody (Santa Cruz sc-7210) and
rabbit IgG secondary to show the amount of protein loaded for each lane.
IE1 Exon-Specific RT-PCR in Latently Infected CD34 (+) HPCs
Total RNAwas isolated from 23 106 10 days postinfection CD34 (+) HPCs and
23 106 4 days postinfection HF cells as previously described (Rossetto et al.,
2013). Five microliters of the RNA was then used in QIAGEN OneStep RT-PCR
Kit reaction following the manufacturer’s instructions, using the strand-spe-
cific primers specific for indicated MIE exons in FixBac (VR-1814). The result-
ing strand-specific PCR products were run on a 1.5% agarose gel using 13
TAE (40mMTris-HCl [pH 7.6], 20mM acetic acid, 1mMEDTA) buffer and visu-
alized by ethidium bromide staining.
Infection of CD34 (+) HPCs with FixBacDEX4 Virus and Evaluation of
Viral DNA Maintenance
FixBacDEX4 virus was generated by transfection of FixBacDEX4 DNA into
HF-IE1 (ihfie1.3)-complementing cell line (Greaves and Mocarski, 1998).(H) Knockdown of Sp1 expression reduces replication of pTR. Sp1 knockdown o
posttreatment DNA was analyzed for DpnI resistance. qPCR was used to mea
separate experiments were performed for all qPCR experiments, and error bars
Figures S6 and S7.
CHF-IE1 cells were transfected with FixBacDEX4 DNA as previously described
(Gao et al., 2010; Supplemental Experimental Procedures).Transient pTR Replication and Maintenance Assays in 293L-IE1x4
Cells
The IE1x4-expressing cell line (0.5 3 106 cells) was transfected with pTR
(1 ug = 24,000 copies/cell) or pGEM (0.3 mg = 24,000 copies/cell) or pTRDSp1
using Mirus TransIT (Supplemental Experimental Procedures).Replication of pTR in Experimentally Latently Infected CD34 (+)
HPCs
CD34 (+) HPCs were isolated from cord blood (deidentified, not human
subjects) using positive isolation and magnetic purification according to the
manufacturer’s instructions (STEMCELL Technologies). For experimentally
infected cells, approximately 0.7 3 106 CD34 (+) cells plus 5 mg (6.6 3 1011
copies) of either TR or oriLyt (5.5 3 1011 copies) containing plasmids were
transfected using a Nucleofector instrument and CD34 (+) kit according to
themanufacturer’s instructions (Lonza) using programU008. After transfection
cells were cultured in normal conditions for 120 hr before DNA was harvested.
Cells were pelleted and DNA was extracted using DNA lysis buffer (2% SDS,
10 mM EDTA, 10 mM Tris-HCl [pH 7.4]) with the addition of 25 mg Proteinase
K and incubated for 2 hr in a 65C water bath, followed by phenol-chloroform
and ethanol precipitation. The final DNA pellet was resuspended in 100 ml 13
TE (pH 7.4) and cleaved with either HindIII alone or HindIII and DpnI for 1 hr in
37C water bath, followed by inactivation at 80C for 20 min. One microliter of
sample DNA was used in a 20 ml TaqMan PCR reaction using TaqMan Univer-
sal PCR 23 master mix (Life Technologies), plus primers and probe. TaqMan
primer and FAM-labeled probes were designed over DpnI junctions of pGEM
that would allow for signal to be detected from only replicated DNA, not input
DNA. The following qPCR program was used: one cycle of 95C hot start for
5 min and 40 cycles of 95C for 15 s and 60C for 1 min. DpnI-resistant DNA
from TR was calculated using HindIII digested alone as the total input value
for each plasmid set and TR fold enrichment over oriLyt DpnI DNA. Input
plasmid determined at 24 hr posttransfection was used to normalize test
samples.ACCESSION NUMBERS
The NCBI SRA accession number for the ChIP-Seq data reported in this paper
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